On 9 February 2012, orphan designation (EU/3/12/956) was granted by the European Commission to PinCell s.r.l., Italy, for human monoclonal antibody against Fas ligand for the treatment of pemphigus.
The sponsor’s address was updated in May 2020.
Human monoclonal antibody against Fas ligand
|Disease / condition||
Treatment of pemphigus
|Date of first decision||
|EU designation number||
Review of designation
Sponsor's contact details
Via Vincenzo Gioberti 8
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.